Zerobase Cream
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Zerobase Cream.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Liquid paraffin 11% w/w.
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Cream.
Zerobase cream is a white, soft cream.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
Zerobase cream is an emollient, moisturising and protective cream for followup treatment with topical steroids or in spacing such treatment. It may also be used as a diluent for topical steroids. Zerobase cream is recommended for the symptomatic treatment of red inflamed, damaged, dry or chapped skin, the protection of raw skin areas and as a pre-bathing emollient for dry/eczematous skin to alleviate drying areas.
4.2 Posology and method of administration
Adults and children:
The cream should be applied to the dry skin areas as often as is required and rubbed well into the skin.
4.3 Contraindications
There are no absolute contraindications to the use of the cream other than hypersensitivity to any of the ingredients.
4.4 Special warnings and precautions for use
If this product comes into contact with dressings and clothes, it can be easily ignited with a naked flame. Patients are advised to avoid fire when using Zerobase Cream.
4.5 Interaction with other medicinal products and other forms of interaction
None relevant.
4.6 Pregnancy and lactation
No risks to pregnant or breastfeeding women have been identified.
4.7 Effects on ability to drive and use machines
None relevant.
4.8. Undesirable Effects
Rarely mild skin reactions have been observed.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
4.9 Overdose
Not relevant.
5.1 Pharmacodynamic properties
The active ingredient in Zerobase cream is liquid paraffin. This provides an emollient, moisturising action on dry or chapped skin.
5.2 Pharmacokinetic properties
Not applicable due to the topical administration and direct action on the skin.
5.3 Preclinical safety data
Not relevant.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
White soft paraffin
Cetostearyl alcohol Cetomacrogol
Sodium dihydrogen phosphate Chlorocresol Phosphoric acid Purified water
6.2 Incompatibilities
Not applicable.
6.3
Shelf life
3 years.
6.4
6.5
Nature and contents of container
500 gram polypropylene container with LDPE lid and pump dispenser. 50 gram lacquered aluminium tube with HDPE screw cap.
7
MARKETING AUTHORISATION HOLDER
Zeroderma Ltd
Linthwaite Laboratories
Linthwaite
Huddersfield
HD75QH
United Kingdom
8
9
23/12/2014